Characterization of continuous B-cell epitopes in the N-terminus of glutamate decarboxylase67 using monoclonal antibodies

Journal of Peptide Science

Volumn 20, Issue 12, 2014, Pages 928-934

  Agca, Selin ^a,b   Houen, Gunnar ^a   Trier, Nicole Hartwig ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Antibody; Enzyme linked immunosorbent assay; Epitope; GAD67; Glutamate decarboxylase; Peptide

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE 67; MONOCLONAL ANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY REACTION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HYDROGEN BOND; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; CHEMISTRY; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; EPITOPES; GLUTAMATE DECARBOXYLASE; MOLECULAR SEQUENCE DATA;

EID: 84919392745     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2703     Document Type: Article

References (50)

1. Fenalti G, Law RH, Buckle AM, Langendorf C, Tuck K, Rosado CJ, Faux NG, Mahmood K, Hampe CS, Banga JP, Wilce M, Schmidberger J, Rossjohn J, El-Kabbani O, Pike RN, Smith AI, Mackay IR, Rowley MJ, Whisstock JC. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat. Struct. Mol. Biol. 2007; 14: 280-286.
2. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylases. Neuron 1991; 7: 91-100.
3. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 2115-2119.
4. Edelhoff S, Grubin CE, Karlsen AE, Alder DA, Foster D, Disteche CM, Lernmark A. Mapping of glutamic acid decarboxylase (GAD) genes. Genomics 1993; 17: 93-97.
5. Ali F, Rowley M, Jayakrishnan B, Teuber S, Gershwin ME, Mackay IR. Stiffperson syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J. Autoimmun. 2011. DOI: 10.1016/j.jaut.2011.05.005.
6. Mackie M, Hughes DI, Maxwell DJ, Tillakaratne NJ, Todd AJ. Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience 2003; 119: 461-472.
7. Feldblum S, ErlanderMG, Tobin AJ. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 1993; 34: 689-706.
8. Faulkner-jones BE, Cram DS, Kun J, Harrison LC. Localization and quantitation of expression of 2 glutamate-gecarboxylase genes in pancreatic beta-cells and other peripheral-tissues of mouse and rat. Endocrinology 1993; 133: 2962-2972.
9. Martin SB, Martin DL. Stimulation by phosphate on the activation of glutamate apodecarboxylase by pyridoxyl-5′-phosphate and its implications for the control of GABA synthesis. J. Neurochem. 1979; 33: 1275-1283.
10. Martin DL, Liu HC, Martin SB, Wu SJ. Structural features and regulatory properties of the brain glutamate decarboxylases. Neurochem. Int. 2000; 37: 111-119.
11. Ge S, Goh EL, Sailor KA, Kitabatake Y, Ming GL, Song H. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 2006; 439: 589-593.
12. Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Ji FY, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem. Biophys. Res. Commun. 1996; 229: 891-895.
13. Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6496-6499.
14. Condie BG, Bain G, Gottlieb DI, Capecchi MR. Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 11451-11455.
15. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 14060-14065.
16. Hagopian WA, Chelsen BM, Karlsen AE, Larsen F, Moody A, Grubin CE, Rowe R, Petersen J, Mcevoy R, Lernmark A. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic-acid decarboxylase. Diabetes 1993; 42: 631-636.
17. Richter W, Seissler J, Northemann W, Wolfahrt A, Meinck HM, Scherbaum WA. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome. Diabetes 1993; 42: 1642-1648.
18. Uibo R, Lernmark A. GAD65 autoimmunity-clinical studies. Adv. Immunol. 2008. DOI: 10.1016/S0065-2776(08)00803-1.
19. Jayakrishnan B, Hoke DE, Langendorf CG, Buckle AM, Rowley MJ. An anaysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes. PLoS One 2011. DOI: 10.1371/journal.pone.0018411.
20. Lundgren VM, Isomaa B, Lyssenko V, Laurila E, Korhonen P, Groop LC, Tuomi T. GAD antibody positivity predicts type 2 diabetes in an adult population. Diabetes 2010. DOI: 10.2337/db09-0747.
21. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-362.
22. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm(Stiff-Man Syndrome) - report of a case and some observations in 13 other cases. Proc. Staff Meet. Mayo Clin. 1956; 31: 421-427.
23. Dalakas MC. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr. Treat. Options. Neurol. 2009; 11: 102-110.
24. Meinck HM, Faber L, Morgenthaler N, Seissler J, Maile S, Butler M, Solimena M, Decamilli P, Scherbaum WA. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J. Neurol. Neurosurg. Psychiatry 2001; 71: 100-103.
25. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 1998; 44: 194-201.
26. Solimena M, Folli F, Aparisi R, Pozza G, Decamilli P. Autoantibodies to gabaergic neurons and pancreatic beta-cells in stiff-man syndrome. N. Engl. J. Med. 1990; 322: 1555-1560.
27. Butler MH, Hayashi A, Ohkoshi N, Villmann C, Becker CM, Feng GP, De Camilli P, Solimena M. Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000; 26: 307-312.
28. Murinson BB, Guarnaccia JB. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 2008. DOI:10.1212/01.wnl.0000327342.58936.e0.
29. Bjork E, Velloso LA, Kample O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43: 161-165.
30. Daw K, Powers AC. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target difference epitopes. Diabetes 1995; 44: 216-220.
31. Tuomi T, Rowley MJ, Knowles WJ, Chen QY, McAnally T, Zimmet PZ, Mackay IR. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin. Immunol. Immunopathol. 1994; 71: 53-59.
32. Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin. Exp. Immunol. 1999; 118: 349-356.
33. Schwartz HL, Chandonia JM, Kash SF, Kanaani J, Tunnell E, Domingo A, Cohen FE, Banga AM, Richter W, Baekkeskov S. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J. Mol. Biol. 1999; 287: 983-999.
34. Luo D, Gilliam LK, Greenbaum C, Bekris L, Hampe CS, Daniels T, Richter W, Marcovina SM, Rolandsson O, Landin-Olsson M, Kockum I, Lernmark A. Conformation-dependent GAD65 autoantibodies in diabetes. Diabetologia 2004; 47: 1581-1591.
35. Sohnlein P, Muller M, Syren K, Hartmann U, Bohm BO, Meinck HM, Knip M, Akerblom HK, Richter W. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. Diabetologia 2000; 43: 210-217.
36. Al-Bukhari TA, Radford PM, Bouras G, Davenport C, Trigwell SM, Bottazzo GF, Lai M, Schwartz HL, Tighe PL, Todd I. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis. Clin. Exp. Immunol. 2002; 130: 131-139.
37. Butler MH, Solimena M, Dirkx R, Hayday A, Decamilli P. Identification of a dominant epitope of glutamic-acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 1993; 178: 2097-2106.
38. Daw K, Ujihara N, Atkinson M, Powers AC. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J. Immunol. 1996; 156: 818-825.
39. Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, Ortqvist E, Hampe CS. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J. Immunol. 2005; 175: 7755-7762.
40. Ziegler B, Schlosser M, Lühder F, Strebelow M, Augstein P, Northemann W, Powers AC, Ziegler M. Murine monoclonal glutamic acid deparboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome. Acta Diabetol. 1996; 33: 25-231.
41. Kringelum JV, Nielsen M, Padkjaer SB, Lund O. Structural analysis of B-cell epitopes in antibody:protein complexes. Mol. Immunol. 2013. DOI:10.1016/j.molimm.2012.06.001.
42. Rubinstein ND, Mayrose I, Halperin D, Yekutieli D, Gershoni JM, Pupko T. Computational characterization of B-cell epitopes. Mol. Immunol. 2008; 45: 3477-3489.
43. Amrutkar SD, Trier NH, Hansen PR, Houen G. Fine mapping of a monoclonal antibody to the N-Methyl D-aspartate receptor reveals a short linear epitope. Biopolymers 2012. DOI: 10.1002/bip.22165.
44. Deshmukh US, Lewis JE, Gaskin F, Kannapell CC, Waters ST, Lou YH, Tung KSK, Fu SM. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J. Exp. Med. 1999; 189: 531-540.
45. Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schoofs PG. Strategies for epitope analysis using peptide-synthesis. J. Immunol. Methods 1987; 102: 259-274.
46. Trier NH, Hansen PR, Vedeler CA, Somnier FE, Houen G. Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases/small cell lung cancer. J. Neuroimmunol. 2012. DOI: 10.1016/j.jneuroim.2011.12.020.
47. Ofran Y, Schlessinger A. Rost B Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B Cell epitopes. J. Immunol. 2008; 181: 6230-6235.
48. Laver WG, Air GM, Webster RG, Smithgill SJ. Epitopes on protein antigens - misconceptions and realities. Cell 1990; 61: 553-556.
49. Welner S, Trier NH, Houen G, Hansen PR. Identification andmapping of a linear epitope of centromere protein F using monoclonal antibodies. J. Pept. Sci. 2013. DOI: 10.1002/psc.2478.
50. Eildal JN, Hultqvist G, Balle T, Stuhr-Hansen N, Padrah S, Gianni S, Stromgaard K, Jemth P. Probing the role of backbone hydrogen bonds in protein-peptide interactions by amide-to-ester mutations. J. Am. Chem. Soc. 2013. DOI: 10.1021/ja402875h.